DGAP-News: Epigenomics AG / Key word(s): Half Year Report/Half Year ResultsEpigenomics AG Reports Financial Results for the First Six Months of 2022 10.08.2022 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for the First Six Months of 2022 Berlin (Germany) and San Diego, CA (U.S.A.), […]
Category: Press Releases
10. August 2022
Epigenomics AG Reports Financial Results for the First Six Months of 2022
Read more
11. May 2022
Epigenomics AG Reports Financial Results for the First Quarter of 2022
DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter ResultsEpigenomics AG Reports Financial Results for the First Quarter of 2022 11.05.2022 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for the First Quarter of 2022 Berlin (Germany) and San Diego, CA (U.S.A.), May 11, […]
24. March 2022
Epigenomics AG Reports Financial Results for Fiscal Year 2021
DGAP-News: Epigenomics AG / Key word(s): Annual Report/Annual Results24.03.2022 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for Fiscal Year 2021 Total revenue of EUR 6.2 million, adjusted EBITDA of EUR -1.8 million FDA clinical trial for Epi proColon “Next Gen” expected to start with […]
24. January 2022
Supervisory Board of Epigenomics AG Retains Greg Hamilton as Chief Executive Officer Through Development of Epi proColon ‘Next-Gen’ Colorectal Cancer Screening Test
DGAP-News: Epigenomics AG / Key word(s): Personnel24.01.2022 / 07:00 The issuer is solely responsible for the content of this announcement. Supervisory Board of Epigenomics AG Retains Greg Hamilton as Chief Executive Officer Through Development of Epi proColon “Next-Gen” Colorectal Cancer Screening Test Greg Hamilton retained as CEO through 2025 Appointment underscores Epigenomics’ commitment to the […]
14. December 2021
Supervisory Board of Epigenomics AG appoints Jens Ravens as Chief Financial Officer
DGAP-News: Epigenomics AG / Key word(s): Personnel14.12.2021 / 07:00 The issuer is solely responsible for the content of this announcement. Supervisory Board of Epigenomics AG appoints Jens Ravens as Chief Financial Officer Jens Ravens is an internationally experienced leader with in-depth experience in Controlling, Finance, M&A, IT, Legal, and Human Resources New Chief Financial Officer […]
18. November 2021
Supervisory Board of Epigenomics AG Appoints Dr. Andrew Lukowiak as President and Chief Scientific Officer
DGAP-News: Epigenomics AG / Key word(s): Personnel18.11.2021 / 08:00 The issuer is solely responsible for the content of this announcement. Supervisory Board of Epigenomics AG Appoints Dr. Andrew Lukowiak as President and Chief Scientific Officer Dr. Andrew Lukowiak is a proven senior executive with deep technology and development expertise Appointment underscores Epigenomics’ commitment to the […]